Illinois Hospital Report Card

and Consumer Guide to Health Care

Riverside Medical Center

Patient Safety - CDI & MRSA

Clostridioides difficile infections (CDI) and Methicillin-resistant Staphylococcus aureus (MRSA) bloodstream infections

Facility-wide Healthcare Facility Onset Incidence Rates for CDI and MRSA are presented below. These rates are based on results of laboratory tests that were obtained on or after day four of an inpatient stay and do not consider presence or timing of clinical signs or symptoms. The Standardized Infection Ratio (SIR) is presented, which is a summary measure used to determine if rates of CDI and MRSA bloodstream infections are statistically different from the national average. Statewide summaries of CDI and MRSA data arranged by hospital are also included. Note: Starting with 2016 data, new methods for risk adjustment were used.

Statistical Significance

Statistically significantly better than the national average or performing at the best possible rate

Not statistically significantly better or worse than the national average

Statistically significantly worse than the national average

Healthcare Facility Onset Incidence Rate	Result	SIR
Methicillin-resistant Staphylococcus aureus (MRSA) blood stream infections Q1 2024 - Q4 2024 Result 0 infections, 44310 patient days Rating SIR: 0.00	0 infections, 44310 patient days	0.00
Description Methicillin-resistant Staphylococcus aureus infections summarized as a Standardized Infection Ratio Historical Data
Measure	Result	Rating
Q1 2023 - Q4 2023 Result 0 infections, 41974 patient days Rating SIR: 0.00	0 infections, 41974 patient days	0.00
Q1 2022 - Q4 2022 Result 2 infections, 43300 patient days Rating SIR: 0.79	2 infections, 43300 patient days	0.79
Q1 2021 - Q4 2021 Result 1 infections, 50970 patient days Rating SIR: 0.37	1 infections, 50970 patient days	0.37
Q1 2020 - Q4 2020 Result 1 infections, 48215 patient days Rating SIR: 0.42	1 infections, 48215 patient days	0.42
Q1 2019 - Q4 2019 Result 2 infections, 53606 patient days Rating SIR: 0.92	2 infections, 53606 patient days	0.92
Q1 2018 - Q4 2018 Result 4 infections, 56572 patient days Rating SIR: 1.51	4 infections, 56572 patient days	1.51
Q1 2017 - Q4 2017 Result 1 infections, 55512 patient days Rating SIR: 0.38	1 infections, 55512 patient days	0.38
Q1 2016 - Q4 2016 Result 1 infections, 61050 patient days Rating SIR: 0.37	1 infections, 61050 patient days	0.37
Q1 2015 - Q4 2015 Result 2 infections, 52531 patient days Rating SIR: 0.62	2 infections, 52531 patient days	0.62
Q1 2014 - Q4 2014 Result 0 infections, 58475 patient days Rating SIR: 0.00	0 infections, 58475 patient days	0.00
Q1 2013 - Q4 2013 Result 2 infections, 60872 patient days Rating SIR: 0.56	2 infections, 60872 patient days	0.56
Q1 2012 - Q4 2012 Result 2 infections, 60014 patient days Rating SIR: 0.67	2 infections, 60014 patient days	0.67
Q1 2012 - Q2 2012 Result 0 infections, 30912 patient days Rating SIR: 0.00	0 infections, 30912 patient days	0.00
Clostridioides difficile infections (CDI) Q1 2024 - Q4 2024 Result 17 infections, 42866 patient days Rating SIR: 0.62	17 infections, 42866 patient days	0.62
Description Clostridium difficile infections summarized as a Standardized Infection Ratio Historical Data
Measure	Result	Rating
Q1 2023 - Q4 2023 Result 10 infections, 40583 patient days Rating SIR: 0.40	10 infections, 40583 patient days	0.40
Q1 2022 - Q4 2022 Result 14 infections, 41914 patient days Rating SIR: 0.53	14 infections, 41914 patient days	0.53
Q1 2021 - Q4 2021 Result 22 infections, 49392 patient days Rating SIR: 0.68	22 infections, 49392 patient days	0.68
Q1 2020 - Q4 2020 Result 14 infections, 46397 patient days Rating SIR: 0.48	14 infections, 46397 patient days	0.48
Q1 2019 - Q4 2019 Result 25 infections, 51195 patient days Rating SIR: 0.76	25 infections, 51195 patient days	0.76
Q1 2018 - Q4 2018 Result 52 infections, 54280 patient days Rating SIR: 1.31	52 infections, 54280 patient days	1.31
Q1 2017 - Q4 2017 Result 18 infections, 53184 patient days Rating SIR: 0.50	18 infections, 53184 patient days	0.50
Q1 2016 - Q4 2016 Result 25 infections, 58719 patient days Rating SIR: 0.67	25 infections, 58719 patient days	0.67
Q1 2015 - Q4 2015 Result 26 infections, 50246 patient days Rating SIR: 0.56	26 infections, 50246 patient days	0.56
Q1 2014 - Q4 2014 Result 25 infections, 57816 patient days Rating SIR: 0.49	25 infections, 57816 patient days	0.49
Q1 2013 - Q4 2013 Result 26 infections, 60872 patient days Rating SIR: 0.47	26 infections, 60872 patient days	0.47
Q1 2012 - Q4 2012 Result 33 infections, 58583 patient days Rating SIR: 0.68	33 infections, 58583 patient days	0.68